Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)

Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)

Andrei-Nicolae Vasilescu,1,* Nina Schweinfurth,2,* Stefan Borgwardt,2,* Peter Gass,1 Undine E Lang,2,* Dragos Inta,1,2,* Sarah Eckart2,* 1Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany; 2Department...

Full description

Bibliographic Details
Main Authors: Vasilescu AN, Schweinfurth N, Borgwardt S, Gass P, Lang UE, Inta D, Eckart S
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Depression
Glutamate
NMDA receptors
Rapastinel
Ketamine
Online Access:https://www.dovepress.com/modulation-of-the-activity-of-n-methyl-d-aspartate-receptors-as-a-nove-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/modulation-of-the-activity-of-n-methyl-d-aspartate-receptors-as-a-nove-peer-reviewed-article-NDT

Similar Items